# The Efficacy of Stabilized Chlorine Dioxide Rinse as a Chemical Adjuvant for Treatment of Per-implant Mucositis

> **NCT04838054** · PHASE4 · COMPLETED · sponsor: **Rowpar Pharmaceuticals, Inc.** · enrollment: 57 (actual)

## Conditions studied

- Peri-implant Mucositis

## Interventions

- **DRUG:** Stabilized chlorine dioxide oral rinse
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04838054
- **Lead sponsor:** Rowpar Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-15
- **Primary completion:** 2020-01-15
- **Final completion:** 2020-03-04
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2022-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04838054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04838054, "The Efficacy of Stabilized Chlorine Dioxide Rinse as a Chemical Adjuvant for Treatment of Per-implant Mucositis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT04838054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*